Kalila Medical, a privately held medical device company focused on the development of next-generation steerable catheter technologies, announced the first US and International use of the Vado Steerable Sheath.
The patented first-of-its-kind steerable sheath uses truVector technology to provide the physician precise catheter tip control during complex electrophysiology (EP) procedures, such as atrial fibrillation (AF) ablation.
In the United States, Andrea Natale M.D., F.A.C.C. of the Texas Cardiac Arrhythmia Institute at St. David’s Medical Center in Austin, TX was among the first users to successfully perform an AF ablation procedure using the Vado sheath. Ian Crozier M.D. and Matthew Daly M.D. of Christchurch Hospital, Christchurch, New Zealand performed the first international use.
"During my procedure, the Vado sheath provided excellent handling and predictable torque response," commented Dr. Natale. "I see a significant need for a device like this to provide accurate catheter positioning during EP procedures, which will save time and physician aggravation."
The innovative Vado sheath is the only steerable sheath that does not require pull wires for tip deflection. Using its patented truVector technology, the Vado sheath is a simple yet innovative coaxial design that can improve torque response, prevent catheter whipping, and provide better navigation ability so that physicians have greater control during procedures.
"We believe the Vado sheath offers significant handling improvements over existing steerable sheaths on the market and we are strongly encouraged and pleased by the initial commercial experience with physicians," stated Mike Dineen, President and CEO of Kalila Medical.
"We look forward to expanding the usage of the Vado steerable sheath over the coming months and building a loyal physician base."